Scor’s $1bn US life liabilities retro arbitration with Covéa prompts analyst concerns

Uncertainty over the outcome of an arbitration dispute between Scor and Covéa over a US life liabilities quota share retrocession contract agreed in 2021 has prompted further analyst scrutiny amid ongoing concerns around the reinsurer’s life and health operations.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com